24/7 Wall Street
14 Jun 2026, 14:57 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Medtronic achieved its strongest annual top-line growth in 10 years, with fiscal 2026 revenue reaching $36.36 billion (up 8.43% year-over-year). — Significant acceleration in revenue growth for a large-cap medical device company suggests strong market share gains and demand.
+0.60Medtronic has increased its dividend for 49 consecutive years and maintains a yield of approximately 3.52%. — Long-term dividend reliability attracts defensive income investors and provides a price floor during volatility.
+0.40Medtronic faces a $185 million tariff headwind and a 230-basis-point compression in non-GAAP operating margins. — Direct costs and margin erosion negatively impact short-term profitability and earnings quality.
-0.30Continue reading
6 related stories
Top 3 movers · tap to explore
Management guides fiscal 2027 organic revenue growth between 6.75% and 7.25% with non-GAAP EPS of $5.90 to $6.00. — Positive forward guidance provides visibility into continued growth and earnings stability.
+0.30Which stocks this story touches
Strong top-line growth, 49 years of dividend increases, and a defensive value proposition despite some margin pressure.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
The Motley Fool
3h ago
